90839-68-2 Usage
General Description
1-(3-chlorophenyl)-1H-1,2,4-triazole-3-carboxylic acid is a chemical compound with a molecular formula C9H6ClN3O2. It is a derivative of 1,2,4-triazole and contains a carboxylic acid functional group. 1-(3-chlorophenyl)-1H-1,2,4-triazole-3-carboxylic acid has various industrial and research applications, including as a building block in the synthesis of pharmaceuticals and agrochemicals. It also has potential antifungal and antibacterial properties, making it a valuable compound in the development of new drugs. 1-(3-chlorophenyl)-1H-1,2,4-triazole-3-carboxylic acid is also a common reagent in organic synthesis and chemical research due to its versatility and important structural features.
Check Digit Verification of cas no
The CAS Registry Mumber 90839-68-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,8,3 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 90839-68:
(7*9)+(6*0)+(5*8)+(4*3)+(3*9)+(2*6)+(1*8)=162
162 % 10 = 2
So 90839-68-2 is a valid CAS Registry Number.
90839-68-2Relevant articles and documents
Monoacylglycerol Lipase Modulators
-
, (2020/04/24)
Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.
NOVEL COMPOUNDS
-
, (2013/06/28)
This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. R1, R2, R3, R4, Q have meanings given in the description.
